Cargando…
Endothelial protective factors BMP9 and BMP10 inhibit CCL2 release by human vascular endothelial cells
Bone morphogenetic protein 9 (BMP9) and BMP10 are circulating ligands that mediate endothelial cell (EC) protection via complexes of the type I receptor ALK1 and the type II receptors activin type-IIA receptor (ACTR-IIA) and bone morphogenetic type II receptor (BMPR-II). We previously demonstrated t...
Autores principales: | Upton, Paul D., Park, John E. S., De Souza, Patricia M., Davies, Rachel J., Griffiths, Mark J. D., Wort, Stephen J., Morrell, Nicholas W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390625/ https://www.ncbi.nlm.nih.gov/pubmed/32576665 http://dx.doi.org/10.1242/jcs.239715 |
Ejemplares similares
-
BMP-9 Induced Endothelial Cell Tubule Formation and Inhibition of Migration Involves Smad1 Driven Endothelin-1 Production
por: Park, John E. S., et al.
Publicado: (2012) -
Correction: BMP-9 Induced Endothelial Cell Tubule Formation and Inhibition of Migration Involves Smad1 Driven Endothelin-1 Production
por: Park, John E. S., et al.
Publicado: (2013) -
Reduced circulating BMP9 and pBMP10 in hospitalized COVID‐19 patients
por: Dunmore, Benjamin J., et al.
Publicado: (2023) -
Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis
por: Owen, Nicola E., et al.
Publicado: (2020) -
High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells
por: Andersson-Rusch, Clara, et al.
Publicado: (2023)